Literature DB >> 604189

Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure.

B Bron, R Waldram, D B Silk, R Williams.   

Abstract

Bile acid levels were measured in the sera, cerebrospinal fluid (CSF), and brain tissue of 10 patients immediately after death from fulminant hepatic (FHF). Serum bile acids in FHF were predominantly conjugated, and total bile acid levels were higher in all 10 patients than in normal controls (85.9 +/- SE 8.4 compared with 5.7 +/- 0.4 nmol/ml, P less than 0.001). Small but significant amounts could be detected in CSF (range 1.2-5.3 nmol total bile acid/ml) and brain biopsies (1.0-18.8 nmol/g wet weight) of FHF patients, whereas none could be detected in CSF and brain biopsies of patients dying without evidence of liver disease. There was no relationship between serum, CSF, or brain levels and duration of coma, or presence of cerebral oedema found in five FHF patients at necropsy. However, serum bile acid levels were similar in FHF to those found in chronic liver disease without encephalopathy and lower than those found to inhibit brain respiration in vitro. A primary role for these compounds in the pathogenesis of coma in FHF therefore seems unlikely.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 604189      PMCID: PMC1411636          DOI: 10.1136/gut.18.9.692

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  INHIBITION OF ELECTRON TRANSPORT AND COUPLED PHOSPHORYLATION IN LIVER MITOCHONDRIA BY CHOLANIC (BILE) ACIDS AND THEIR CONJUGATES.

Authors:  M J LEE; M W WHITEHOUSE
Journal:  Biochim Biophys Acta       Date:  1965-05-04

2.  On the turnover and excretory products of cholic and chenodeoxycholic acid in man.

Authors:  H DANIELSSON; P ENEROTH; K HELLSTROM; S LINDSTEDT; J SJOVALL
Journal:  J Biol Chem       Date:  1963-07       Impact factor: 5.157

3.  Cerebral metabolism in hepatic insufficiency.

Authors:  R W ALMAN; W R EHRMANTRAUT; J F FAZEKAS; H E TICKTIN
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

4.  Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

Authors:  B G Gazzard; M J Weston; I M Murray-Lyon; H Flax; C O Record; R Williams; B Portmann; P G Langley; E H Dunlop; P J Mellon; M B Ward
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

5.  Inhibition of active hexose and amino acid transport by conjugated bile salts in rat ileum.

Authors:  W F Caspary
Journal:  Eur J Clin Invest       Date:  1974-02       Impact factor: 4.686

6.  Determination of bile acids in needle biopsies of human liver.

Authors:  H Greim; P Czygan; F Schaffner; H Popper
Journal:  Biochem Med       Date:  1973-10

7.  Studies on the effects of unconjugated dihydroxy bile salts on rat small intestinal function in vivo.

Authors:  G E Sladen; J T Harries
Journal:  Biochim Biophys Acta       Date:  1972-11-02

8.  [Encephalopathy in acute hepatic atrophy. Effect of the purification of middle molecules. Preliminary results].

Authors:  P Opolon; M C Lavallard; C Crubille; P Gateau; V Nusinovici; A Granger; F Darnis; J Caroli
Journal:  Nouv Presse Med       Date:  1975-12-06

9.  Small intestinal mucosal injury in the experimental blind loop syndrome. Light- and electron-microscopic and histochemical studies.

Authors:  P P Toskes; R A Giannella; H R Jervis; W R Rout; A Takeuchi
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

10.  Serum bile acids in primary biliary cirrhosis.

Authors:  G M Murphy; A Ross; B H Billing
Journal:  Gut       Date:  1972-03       Impact factor: 23.059

View more
  17 in total

1.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Samir Ashfaq; Mario de los Santos; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2015-12-09       Impact factor: 4.307

2.  Bile Acids in Hepatic Encephalopathy.

Authors:  Sharon DeMorrow
Journal:  J Clin Exp Hepatol       Date:  2018-05-04

3.  Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor β1.

Authors:  Brandi Jefferson; Malaika Ali; Stephanie Grant; Gabriel Frampton; Michaela Ploof; Sarah Andry; Sharon DeMorrow; Matthew McMillin
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

4.  The TGR5 receptor mediates bile acid-induced itch and analgesia.

Authors:  Farzad Alemi; Edwin Kwon; Daniel P Poole; TinaMarie Lieu; Victoria Lyo; Fiore Cattaruzza; Ferda Cevikbas; Martin Steinhoff; Romina Nassini; Serena Materazzi; Raquel Guerrero-Alba; Eduardo Valdez-Morales; Graeme S Cottrell; Kristina Schoonjans; Pierangelo Geppetti; Stephen J Vanner; Nigel W Bunnett; Carlos U Corvera
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 5.  Effects of bile acids on neurological function and disease.

Authors:  Matthew McMillin; Sharon DeMorrow
Journal:  FASEB J       Date:  2016-07-28       Impact factor: 5.191

6.  Potential toxins of acute liver failure and their effects on blood-brain barrier permeability.

Authors:  A E Zaki; E N Wardle; J Canalese; R J Ede; R Williams
Journal:  Experientia       Date:  1983-09-15

7.  Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice.

Authors:  Stephanie Grant; Matthew McMillin; Gabriel Frampton; Anca D Petrescu; Elaina Williams; Victoria Jaeger; Jessica Kain; Sharon DeMorrow
Journal:  Gene Expr       Date:  2018-06-12

8.  Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers.

Authors:  Xue-Qing Li; Roslyn Stella Thelingwani; Leif Bertilsson; Ulf Diczfalusy; Tommy B Andersson; Collen Masimirembwa
Journal:  J Pers Med       Date:  2021-05-24

Review 9.  Recent advances in hepatic encephalopathy.

Authors:  Victoria Liere; Gurkarminder Sandhu; Sharon DeMorrow
Journal:  F1000Res       Date:  2017-09-04

10.  Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice.

Authors:  Matthew McMillin; Gabriel Frampton; Stephanie Grant; Shamyal Khan; Juan Diocares; Anca Petrescu; Amy Wyatt; Jessica Kain; Brandi Jefferson; Sharon DeMorrow
Journal:  Front Cell Neurosci       Date:  2017-07-05       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.